Are you Dr. Malinoski?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 43 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1115 Willow Pond Ln
Leland, NC 28451Phone+1 910-599-7058- Is this information wrong?
Summary
- Dr. Frank Malinoski, MD is a family physician in Leland, North Carolina. He is currently licensed to practice medicine in North Carolina and Maryland.
Education & Training
- San Antonio Uniformed Services Health Education ConsortiumInternship, Transitional Year, 1985 - 1986
- Albany Medical CollegeClass of 1985
Certifications & Licensure
- MD State Medical License 1986 - 2017
- NC State Medical License 2011 - 2016
Clinical Trials
- Study to Evaluate the Incidence of Hospitalizations and Respiratory Tract Infections in Premature Infants Start of enrollment: 2006 Oct 01
- A Study Evaluating the Safety and Tolerability of a Seasonal Influenza Vaccine Containing LIQ001 Start of enrollment: 2010 Sep 01
Publications & Presentations
PubMed
- 7 citationsThe nanomedicines alliance: an industry perspective on nanomedicinesFrank J. Malinoski> ;Nanomedicine. 2014 Nov 1
- 15 citationsEngineered PRINT(®) nanoparticles for controlled delivery of antigens and immunostimulants.Anton Beletskii, Ashley Galloway, Shyam Rele, Michele R. Stone, Frank J. Malinoski> ;Human Vaccines & Immunotherapeutics. 2014 Apr 22
- Engineered PRINT(®) nanoparticles for controlled delivery of antigens and immunostimulants.Beletskii, A.,Galloway, A.,Rele, S.,Stone, M.,Malinoski, F.> ;Hum Vaccin Immunother. 2014 Apr 24
- Join now to see all
Press Mentions
- Eveliqure Announces Initiation of Phase 1 Clinical Study for Shigella and ETEC Vaccine CandidateSeptember 24th, 2020
- Eveliqure Announces Regulatory Approval to Commence First Clinical Studies with Its Combined Shigella and ETEC VaccineJune 9th, 2020
- Frank Malinoski, MD, PhD, Joins Affinivax as Senior Vice President of Clinical Development and Regulatory AffairsApril 16th, 2019